mAbVista Overview
- Founded
-
2011
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
mAbVista General Information
Description
Operator of a biotechnology firm designed to specialize in the production of high quality monoclonal antibodies. The company's products provides highly specific, sensitive and versatile microscopy-qualified monoclonal antibodies for the acceleration and advancement of proteomics, enabling researchers to perform quantitative single cell analysis and high content drug screening.
Contact Information
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
- Two Greenway Plaza
- Suite 910
- Houston, TX 77046
- United States
mAbVista Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Sep-2019 | Completed | Out of Business | |||
| 1. Early Stage VC | Completed | Generating Revenue |